Geoff Meyerson is CEO and Co-founder of Locust Walk.  He brings a track record of success in investment banking, venture capital and licensing where he has closed >60 transactions of all varieties including playing a role in a majority of Locust Walk’s closed transactions. 

Prior to Locust Walk, Geoff worked in business development at a venture-backed biotech company, in venture capital at SR One, in business development at MedImmune, and investment banking in UBS’ Global Healthcare Investment Banking Group. 

He holds an MBA in Health Care Management from the Wharton School, a Masters in Biotechnology from the University of Pennsylvania, and a BS in Economics from Duke University. 

Geoff founded and is the President of an exclusive relationship building organization called BioBreak. He is a member of the Young Presidents Organization New England Chapter and is on the Board of Overseers for Beth Israel Lahey Health.  Geoff has also served on the board of the Wharton Health Care Management Alumni Association.  He was named by Wharton Magazine and the Philadelphia Business Journal to their 40 Under 40 list for 2017 and 2010, respectively. 

He is a registered rep with FINRA holding his Series 79, 63, 24, 86, and 87 licenses.